Abstract
The effect of methionine on the uptake, distribution, and binding of the convulsant methionine sulfoximine (MSO) in 7 rat brain regions, the spinal cord, the liver, and the kidney was investigated. The administration of methionine decreased the uptake of MSO in all brain regions. The uptake of MSO by and its distribution in the nervous tissue was uniform and failed to result in any preferential accumulation of the drug. Methionine decreased the amount of MSO bound to cerebral structures and to the spinal cord. MSO bound to the spinal cord was less susceptible to release by Triton X-100 than was brain-bound MSO.
Similar content being viewed by others
References
Peters, E.L., andTower, D.B. 1959. Glutamic acid and glutamine metabolism in cerebral cortex after seizures induced by methionine sulfoximine. J. Neurochem. 5:80–90.
Van den Berg, C.J., andVan Den Velden, J. 1970. The effect of methionine sulfoximine on the incorporation of labelled glucose, acetate, phenylalanine and proline into glutamate and related amino acids in the brains of mice. J. Neurochem. 17:985–991.
Sellinger, O.Z., Azcurra, J.M., andOhlsson, W.G. 1968. Methionine sulfoximine seizures VIII. The dissociation of the convulsant and glutamine synthetase inhibitory effects. J. Pharmacol. Exp. Ther. 164:212–222.
Tews, J.K., andStone, W.E. 1964. Effects of methionine sulfoximine on levels of free amino acids and related substances in brain. Biochem. Pharmacol. 13:543–545.
Ghittoni, N.E., andSellinger, O.Z. 1970. Cerebral methionine and cysteine levels in rats after injection of the convulsant methionine sulfoximine. Pharmacol. Res. Commun. 2:117–120.
Stransky, Z. 1969. Time course of rat brain GABA levels following methionine sulfoximine treatment. Nature (London) 224:612–613.
Folbergrova, J., Passonneau, J.V., Lowry, O.H., andSchulz, D.W. 1969. Glycogen, ammonia and related metabolites in the brain during seizures evoked by methionine sulfoximine. J. Neurochem. 16:191–203.
Hindfelt, B., andPlum, F. 1975.L-methionineDl-sulfoximine and acute ammonia toxicity. J. Pharm. Pharmacol. 27:456–458.
DeRobertis, E., Sellinger, O.Z., Rodriguez de Lores Arnaiz, G., Alberici, M., andZieher, L.M. 1967. Nerve endings in the methionine sulphoximine convulsant rats, a neurochemical and ultrastructural study. J. Neurochem. 14:81–89.
Schatz, R.A., andSellinger, O.Z. 1975. The elevation of cerebral histamine-N-and catechol-O-methyl transferase activities byL-methionine-dl-sulfoximine. J. Neurochem. 25:73–78.
Phelps, C.H. 1975. An ultrastrural study of methionine sulphoximine-induced glycogen accumulation in astrocytes of the mouse cerebral cortex. J. Neurocytol. 4:479–490.
Sellinger, O.Z., Azcurra, J.M., Ohlsson, W.G., Kohl, H.H., andZand, R. 1972. Neurochemical correlates of drug-induced seizures: Selective inhibition of cerebral protein synthesis by methionine sulfoximine. Fed. Proc. 31:160–165.
Folbergrova, J. 1962. Effect ofD,l-methionine sulfoximine on incorporation of [35S]-methionine into proteins of brain cortex slices. Nature 194:871–873.
Lisy, V., andLodin, Z. 1975. The influence ofL-methionine-D,l-sulfoximine on the labelling of acid soluble fraction and proteins of the brain cortex after intraperitoneal injection of14C-leucine. Exp. Pathol. (Jena) 10:211–215.
Rizzuto, N., andGonatas, N.K. 1974. Ultrastructural study of the effect of methionine sulfoximine on developing and adult rat cerebral cortex. J. Neuropathol. Exp. Neurol. 33:237–251.
Gutierrez, J.A., andNorenberg, M.D. 1975. Alzheimer II astrocytosis following methionine sulfoximine. Arch. Neurol. 32:123–126.
Reiner, L., Misani, F., andWeiss, P. 1950. Studies on nitrogen trichloride treated prolamines. VI. Suppression of the development of convulsions with methionine. Arch. Biochem. 25:447–454.
Lodin, Z., andKolousek, J. 1958. The effect of some amino acids on the neurotoxic action of methionine sulfoximine. Physiol. Bohemosl. 7:87–94.
Tower, D.B., andElliott, K.A.C. 1953. Experimental production and control of an abnormality in acetylcholine metabolism present in epileptogenic cortex. J. Appl. Physiol. 5:375–391.
Schatz, R.A., andSellinger, O.Z. 1975. Effect of methionine and methionine sulfoximine on rat brainS-adenosyl methionine levels. J. Neurochem. 24:63–66.
Roth, J.S., Wase, A., andReiner, L. 1952. The distribution of S35-labeledL-methionine sulfoximine in the rat. Science 115:236–238.
Ghittoni, N.E., Ohlsson, W.G., andSellinger, O.Z. 1970. The effect of methionine on the regional and intracellular disposition of [3H]-methionine sulfoximine in rat brain. J. Neurochem. 17:1057–1068.
Brink, J.J., andSellinger, O.Z. 1967. A rapid, preparative separation of methionine sulfoximine from methionine sulfoxide. J. Chromatog. 27:269–270.
Glowinski, J., andIversen, L.L. 1966. Regional studies of catecholamines in the rat brain. I. The disposition of H3 norepinephrine, H3 dopamine and H3 dopa in various regions of the brain. J. Neurochem. 13:655–669.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., andRandall, R.J. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265–275.
Rao, S.L.N., andMeister, A. 1972.In vivo formation of methionine sulfoximine phosphate, a protein-bound metabolite of methionine sulfoximine. Biochem. 11:1123–1127.
Lamar, C., Jr., andSellinger, O.Z. 1965. The inhibitionin vivo of cerebral glutamine synthetase and glutamine transferase by the convulsant methionine sulfoximine. Biochem. Pharmacol. 14:489–506.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schatz, R.A., Harris, R. & Sellinger, O.Z. The effect of methionine on the uptake, distribution, and binding of the convulsant methionine sulfoximine in the rat. Neurochem Res 1, 53–63 (1976). https://doi.org/10.1007/BF00965631
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00965631